当前位置: X-MOL 学术Folia Neuropathol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Valproic acid for myoclonic epilepsy in POLG1 carriers can be fatal
Folia Neuropathologica ( IF 1.5 ) Pub Date : 2021-03-31 , DOI: 10.5114/fn.2021.104542
Josef Finsterer 1
Affiliation  

With interest we read the article by Tarka et al. about the autopsy findings of an 8-year-old female with mitochondrial disorder (MID) due to the compound heterozygous variants c.2243G>C and c.2542G>A in POLG1 [1]. The patient manifested clinically with mental retardation, developmental regression, and myoclonic epilepsy, for which she received valproic acid (VPA) [1]. Neuropathological studies after death from acute pancreatitis and liver failure revealed bilaterally symmetric degenerative lesions of the accessory olivary nuclei in addition to typical features of Alpers-Huttenlocher disease (AHD) [1]. It was concluded that pancreatitis prior to liver failure is unusual [1]. The study is appealing but raises comments and concerns.

中文翻译:

POLG1 携带者肌阵挛性癫痫的丙戊酸可能是致命的

我们饶有兴趣地阅读了 Tarka 等人的文章。关于一名 8 岁女性因 POLG1 中的复合杂合变异 c.2243G>C 和 c.2542G>A 而患有线粒体疾病 (MID) 的尸检结果 [1]。患者临床表现为智力低下、发育倒退和肌阵挛性癫痫,为此她接受了丙戊酸 (VPA) [1]。急性胰腺炎和肝功能衰竭死亡后的神经病理学研究显示,除了 Alpers-Huttenlocher 病 (AHD) 的典型特征外,副橄榄核还出现双侧对称的退行性病变 [1]。得出的结论是,肝功能衰竭前的胰腺炎并不常见[1]。这项研究很有吸引力,但也引发了评论和担忧。
更新日期:2021-04-13
down
wechat
bug